fusobacterium nucleatum atcc 10953 (ATCC)
Structured Review
Fusobacterium Nucleatum Atcc 10953, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 176 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fusobacterium+nucleatum+subsp+polymorphum/Fusobacterium+nucleatum%3B+subsp%2E+polymorphum/pm41820945-87-5-7
Average 96 stars, based on 176 article reviews
Images
Related Articles
Incubation:Article Title: Delivery of short chain fatty acid butyrate to overcome Fusobacterium nucleatum-induced chemoresistance. Article Snippet: The gut microbiota is closely associated with the progression of colorectal cancer (CRC) in which Fusobacterium nucleatum (F. nucleatum) was found to induce cancer resistance to chemotherapeutics.. To relieve F. nucleatuminduced drug resistance, herein, we found that short-chain fatty acid butyrate can inhibit the growth, enrichment and adhesion of F. nucleatum in colorectal cancer tissues by downregulating the expression of adhesionassociated outer membrane proteins, including RadD, FomA, and FadA, to reduce the colonization and invasion of F. nucleatum and relieve the chemoresistance induced by F. nucleatum.. Leveraging the killing effect of butyrate on F. nucleatum, sodium butyrate (NaBu) was encapsulated in liposomes or prepared as NaBu tablets with Eudragit S100 coating and administered by intravenous injection or oral administration, respectively. Isolation:Article Title: Tumor-infiltrating bacteria disrupt cancer epithelial cell interactions and induce cell-cycle arrest Article Snippet: Fusobacterium nucleatum subsp. nucleatum , ATCC bacterial strain isolated from a cervico-facial lesion , ATCC 25586. .. Cell Culture:Article Title: Delivery of short chain fatty acid butyrate to overcome Fusobacterium nucleatum-induced chemoresistance. Article Snippet: The gut microbiota is closely associated with the progression of colorectal cancer (CRC) in which Fusobacterium nucleatum (F. nucleatum) was found to induce cancer resistance to chemotherapeutics.. To relieve F. nucleatuminduced drug resistance, herein, we found that short-chain fatty acid butyrate can inhibit the growth, enrichment and adhesion of F. nucleatum in colorectal cancer tissues by downregulating the expression of adhesionassociated outer membrane proteins, including RadD, FomA, and FadA, to reduce the colonization and invasion of F. nucleatum and relieve the chemoresistance induced by F. nucleatum.. Leveraging the killing effect of butyrate on F. nucleatum, sodium butyrate (NaBu) was encapsulated in liposomes or prepared as NaBu tablets with Eudragit S100 coating and administered by intravenous injection or oral administration, respectively. Positive Control:Article Title: Hidden palette: Culturing the sauropsid gut microbiome reveals a high prevalence and diversity of bacteria that undergo carotenoid biosynthesis Article Snippet: For anaerobic cultivation (avian samples only), BHI plates were prepared and pre-reduced by placing them in an anaerobic container (Mitsubishi Gas Chemical) overnight. .. Samples were processed as previously described, but our positive control was other:Article Title: Associations Between Oral Microbiota Pathogens and Elevated Depressive and Anxiety Symptoms in Men Article Snippet: Fusobacterium nucleatum subsp. polymorphum 390 89.4 % 0.5 Bacteria:Article Title: Antibacterial and oral tissue effectiveness of a mouthwash with a novel active system of amine + zinc lactate + fluoride Article Snippet: .. Five representative oral bacteria were used: Actinomyces viscosus , Lactobacillus casei (ATCC#334), |
